Roche Holding AG (RO)

Switzerland


	Symbol		Exchange		Currency
	RO		Switzerland		CHF	Delayed
	ROG		Switzerland		CHF	Delayed
	ROz		BATS Europe		CHF	Delayed
	ROGz		BATS Europe		CHF	Delayed
	RHHVF		OTC Markets		USD	Delayed
	RHHBY		OTC Markets		USD	Delayed
	0QOK		London		CHF	Real-time
	0QQ6		London		CHF	Real-time
	ROGN		Mexico		MXN	Delayed
	RHO6y		Frankfurt		EUR	Delayed

Currency in CHF

Disclaimer

291.80

+3.80(+1.32%)

Closed11/10

Fair Value

Day's Range

287.20

291.80

52 wk Range

229.40

312.00

RO Income Statement

Featured here, the Income Statement (earnings report) for Roche Holding AG, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

63,751

60,343

65,850

65,814

60,441

Total Revenues Growth

+7.15%

-5.35%

+9.13%

-0.05%

-8.16%

Cost Of Revenues

17,385

15,861

19,360

17,938

15,597

Gross Profit

46,366

44,482

46,490

47,876

44,844

Gross Profit Growth

+7.89%

-4.06%

+4.51%

+2.98%

-6.33%

Gross Profit Margin %

72.73%

73.72%

70.6%

72.74%

74.19%

Other Operating Expenses, Total

25,333

24,785

26,237

27,307

27,065

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+5.3%	-2.16%	+5.86%	+4.08%	-0.89%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	11,923	12,566	14,022	13,599	13,545
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	13,183	11,954	11,977	13,691	13,486
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	227	265	238	17	34

Operating Income

21,033

19,697

20,253

20,569

17,779

Operating Income Growth

+11.17%

-6.35%

+2.82%

+1.56%

-13.56%

EBIT Margin %

32.99%

32.64%

30.76%

31.25%

29.42%

Net Interest Expenses

-520

-422

-342

-568

-633

Net Interest Expenses Growth

+9.41%

+18.85%

+18.96%

-66.08%

-11.44%

Interest Expense, Total

-620

-438

-342

-608

-828

Interest And Investment Income

100

16

-

40

195

Other Non Operating Expenses, Total

-244

-205

-229

-409

-289

EBT, Excl. Unusual Items

20,269

19,070

19,682

19,592

16,857

Gain (Loss) On Sale Of Assets

-

-

-

618

569

Other Unusual Items, Total

-1,860

-111

-776

-2,867

-698

EBT, Incl. Unusual Items

16,614

17,965

17,398

16,327

14,079

EBT, Incl. Unusual Items Growth

+17.43%

+8.13%

-3.16%

-6.16%

-13.77%

EBT, Incl. Unusual Items Margin

26.06%

29.77%

26.42%

24.81%

23.29%

Income Tax Expense

2,506

2,897

2,463

2,796

1,721

Net Income to Company

14,108

15,068

14,935

13,531

12,358

Minority Interest

-611

-773

-1,005

-1,110

-860

Net Income

13,497

14,295

13,930

12,421

11,498

Net Income Growth

+28.54%

+5.91%

-2.55%

-10.83%

-7.43%

Net Income Margin %

21.17%

23.69%

21.15%

18.87%

19.02%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

13,497

14,295

13,930

12,421

11,498

Basic EPS - Continuing Operations

15.77

16.72

16.39

15.53

14.39

Basic EPS - Continuing Operations Growth

+28.24%

+6.04%

-1.98%

-5.26%

-7.32%

Diluted EPS - Continuing Operations

15.62

16.52

16.2

15.37

14.31

Diluted EPS - Continuing Operations Growth

+27.94%

+5.8%

-1.99%

-5.1%

-6.9%

Basic Weighted Average Shares Outstanding

856

855

850

800

799

Diluted Weighted Average Shares Outstanding

864

865

860

808

804

Dividend Per Share

9

9.1

9.3

9.5

9.6

Dividend Per Share Growth

+3.45%

+1.11%

+2.2%

+2.15%

+1.05%

EBITDA

24,974

23,898

24,333

24,072

20,918

EBITDA Growth

+10.97%

-4.31%

+1.82%

-1.07%

-13.1%

EBITDA Margin %